← Browse by Condition
Medical Condition

unresectable metastatic melanoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT02821013 Phase 3
Recruiting

Duration of Anti-PD-1 Therapy in Metastatic Melanoma

Enrollment
614 pts
Location
Australia, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →